Lexpos News

MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/19 Date issued: 20 April 2026 Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-39191133 Company name: Crescent Pharma Limited Medicine Details Ramipril [...]

The post MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.

Formal processes to seek a new East and North Midlands Regional Representative will begin shortly, following the resignation of Lindsey Fairbrother from the Committee. Our committee is responsible for providing effective leadership to and oversight of Community Pharmacy England’s activity to generate value for the sector and promote the long-term success of community pharmacy in [...]

The post East and North Midlands Independent Regional Representative Election appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (17/04/2026) confirmed the following initial list of price concessions for April 2026: Drug Pack size Price concession Aspirin 75mg gastro-resistant tablets 28 £2.15 Benzydamine 0.15% mouthwash sugar free 300 £3.15 Carbocisteine 375mg capsules 120 £2.96 Carvedilol 12.5mg tablets 28 £3.99 Carvedilol 25mg tablets 28 £4.17 Carvedilol [...]

The post April 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

NHS England is updating the process for supplying medicines when people leave prison. The changes, aims to improve continuity of care and reduce pressure on community pharmacies and GP practices during a patient’s first days and weeks back in the community. Following the updated process, most people leaving prison will now be issued with a [...]

The post Detained estate EPS prescribing: medicines supply process update appeared first on Community Pharmacy England.

Overview Community pharmacies across North East London took part in a pilot programme commissioned by Barts Health NHS Trust to deliver cholesterol point of care testing (POCT). The initiative formed part of a wider strategy to address declining cardiovascular disease (CVD) detection rates following the COVID-19 pandemic, during which routine monitoring significantly decreased. By offering [...]

The post Service case study: Cholesterol Point of Care Testing in community pharmacy appeared first on Community Pharmacy England.